yaminiamrale

1
Human Microbiome Therapeutics MarketSet to
Exceed 1,544.6 Million By 2027 CAGR 23.8

• Human Microbiome Therapeutics Market Share,
  Size, Trends, Industry Analysis Report, By
  Product (Probiotics, Prebiotics, Medical Foods,
  and Prescription Drugs) By Therapeutic Area
  (Autoimmune Disorders, Dental Disorders,
  Digestive and Gastrointestinal Disorders,
  Dermatological Disorders, Infectious Disease,
  Metabolic Disorders, Oncology, and Others) By
  Indication By Approach By Regions Segment
  Forecast, 2020 2027

2
Human Microbiome Therapeutics Market Estimate
Forecast to 2027
The global human microbiome therapeutics market
size is expected to reach USD 1,544.6 million by
2027 according to a new study by Polaris Market
Research. The report Human Microbiome
Therapeutics Market Share, Size, Trends, Industry
Analysis Report, By Product (Probiotics,
Prebiotics, Medical Foods, and Prescription
Drugs) By Therapeutic Area (Autoimmune
Disorders, Dental Disorders, Digestive and
Gastrointestinal Disorders, Dermatological
Disorders, Infectious Disease, Metabolic
Disorders, Oncology, and Others) By Indication
(Acne Vulgaris, Atopic Dermatitis, Clostridium
difficile Infection, Colorectal Cancer, Diabetes,
Inflammatory Bowel Disease (IBD), Lactose
Intolerance, Lung Cancer, Non-alcoholic
steatohepatitis (NASH), Obesity, and Coeliac
Disease) By Approach (Small Molecule Therapies,
Single Strain Whole Bacteria, Microbial
Consortia, Genetically Modified Single Strain
Bacteria, Phage Cocktail, and Microbial
Ecosystems), By Regions Segment Forecast, 2020
2027 gives a detailed insight into current
market dynamics and provides analysis on future
market growth. Microbiome refers to the residing
micro-organisms genomes in the human body,
particularly in the gut. The human body comprises
more than 100 trillion microbes and around 2
million microbe genomes. These microbiota plays a
significant role in the bodys physiological
functions and includes viruses, bacteria, and
fungi. Primarily it has Bacteroidetes (gram
negative) and Firmicutes, commonly Clostridium
and Lactobacillus sp. (gram positive). The
majority of these are strict anaerobes, with
fungi and archaebacteria comprising less than 1
per cent of the total population.
3
Human Microbiome Therapeutics Market Scope
By Product By Therapeutic Areas By Indication
Probiotics Prebiotics Medical Foods Prescription Drugs Autoimmune Disorders Dental Disorders Digestive and Gastrointestinal Disorders Dermatological Disorders Infectious Disease Metabolic Disorders Oncology Others Acne Vulgaris Atopic Dermatitis Clostridium difficile Infection Colorectal Cancer Diabetes Inflammatory Bowel Disease (IBD) Lactose Intolerance Lung Cancer Non-alcoholic steatohepatitis (NASH) Obesity Coeliac Disease
By Region
North America (U.S., Canada) Europe (Germany, UK, France, Italy, Spain) Asia Pacific (China, India, Japan, South Korea) Latin America (Brazil, Mexico, Colombia) MEA (Saudi Arabia, South Africa, Israel, UAE)
By Approach
Small Molecule Therapies Single Strain Whole Bacteria Microbial Consortia Genetically Modified Single Strain Bacteria Phage Cocktail Microbial Ecosystems
Request for sample
4
Human Microbiome Therapeutics Market Estimate
Forecast to 2027
The global market is driven by an increased focus
on microbiome based early diagnosis of diseases,
increase in the prevalence of diseases due to
dysbiosis, rising collaborations, and strongly
funded government backed microbiome research
projects. In November 2019, the Million
Microbiome of Humans Project (MMHP) was launched
in collaboration with France, Denmark, China,
Latvia, Sweden and other countries to co-operate
in meta-genomic research. The aim is to create
the largest human microbiome database from
analyzing more than one million samples gathered
from reproductive tract, gut, skin, and other
organs in the next few years. Access Research
Report On Human Microbiome Therapeutics
Market   Market participants such as Enterome
Bioscience, Biotagenics, Seres Therapeutics,
Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D
Pharma PLC, UBiome, Carbiotix, E.I. du Pont de
Nemours and Company, Finch Therapeutics,
GNUbiotics Sciences, ClearB Therapeutics,
GoodBelly, GoodGut, Synlogic, Second Genome, 16S
Technologies, 5QBD-Biotech, Vedanta Biosciences,
Holobiome, Commense, Ferring Pharmaceuticals,
Evelo Biosciences, CoreBiome, Igen Biolab Group,
ViThera Pharmaceuticals, DermBiont, Hyggut,
Embion Technologies, Lactobio, BiomX, Exeliom
Biosciences, and LNC Therapeutics are some of the
key players operating in the concerned market.
5
Human Microbiome Therapeutics Market Size
Speak To Analyst
6
Human Microbiome Therapeutics Market Study
Engagement Options
Buy Now Click Here!

• Buy now have immediate access to premium
  insights

Purchase Report Sections Click Here!

• Regional analysis
• Segmentation analysis
• Industry outlook
• Competitive landscape

Speak To Analyst Click Here!

• Get your doubts clear
• Schedule a call with our analyst before making
  any decision

Request For Sample Pages Click Here!

• Get free sample pages
• Understand report structure
• Unmask data for validation

7
About Us
Polaris Market Research is a global market
research and consulting company. The company
specializes in providing exceptional market
intelligence and in-depth business research
services for our clientele spread across
different enterprises. We at Polaris are obliged
to e present across the industries of healthcare,
technology, semi-conductors and chemicals among
various other industries present around the
world. We strive to provide our customers with
updated information on innovative technologies,
high growth markets, emerging business
environments and latest business-centric
applications, thereby helping them always to make
informed decisions and leverage new
opportunities. Adept with a highly competent,
experienced and extremely qualified team of
experts comprising SMEs, analysts and
consultants, we at Polaris endeavor to deliver
value-added business solutions to our
customers.   Web www.polarismarketresearch.com Of
ficial Blog http//polarismarketresearch.blogspot
.com/
8
Thank You!
Contact Us Polaris Market Research30 Wall
Street8th Floor, New York City, NY
10005,United States E mail Id
sales_at_polarismarketresearch.com Phone
1-646-568-9980